Catalyst Wire Dossier Catalyst Wire Dossier

YCANTH

cantharidin · Verrica Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YCANTH, covering 2023-07-21 to 2023-07-21. Get the full timeline:

Most recent: FDA Approved: YCANTH — Original Application (Verrica Pharmaceuticals Inc.)

See pricing